Literature DB >> 22452816

Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma.

Daniel L Miller1, Michael D Puricelli, M Sharon Stack.   

Abstract

The current literature fully supports HPV (human papillomavirus)-associated OPSCC (oropharyngeal squamous cell carcinoma) as a unique clinical entity. It affects an unambiguous patient population with defined risk factors, has a genetic expression pattern more similar to cervical squamous cell carcinoma than non-HPV-associated HNSCC (head and neck squamous cell carcinoma), and may warrant divergent clinical management compared with HNSCC associated with traditional risk factors. However, a detailed understanding of the molecular mechanisms driving these differences and the ability to exploit this knowledge to improve clinical management of OPSCC has not yet come to fruition. The present review summarizes the aetiology of HPV-positive (HPV+) OPSCC and provides a detailed overview of HPV virology and molecular pathogenesis relevant to infection of oropharyngeal tissues. Methods of detection and differential gene expression analyses are also summarized. Future research into mechanisms that mediate tropism of HPV to oropharyngeal tissues, improved detection strategies and the pathophysiological significance of altered gene and microRNA expression profiles is warranted.

Entities:  

Mesh:

Year:  2012        PMID: 22452816      PMCID: PMC3571652          DOI: 10.1042/BJ20112017

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  143 in total

1.  Two patches of amino acids on the E2 DNA binding domain define the surface for interaction with E1.

Authors:  G Chen; A Stenlund
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  A causal role for human papillomavirus in head and neck cancer.

Authors:  M L Gillison; D R Lowy
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

Review 3.  Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system.

Authors:  Margaret Brandwein-Gensler; Richard V Smith
Journal:  Head Neck Pathol       Date:  2010-02-06

4.  Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States--possible role for human papillomavirus in survival disparities.

Authors:  Travis P Schrank; Yimei Han; Heidi Weiss; Vicente A Resto
Journal:  Head Neck       Date:  2011-01       Impact factor: 3.147

5.  High-risk human papillomavirus and cervical lymph node metastasis in patients with oropharyngeal cancer.

Authors:  Young-Hoon Joo; Chan-Kwon Jung; Dong-Il Sun; Jun-Ook Park; Kwang-Jae Cho; Min-Sik Kim
Journal:  Head Neck       Date:  2011-03-24       Impact factor: 3.147

6.  p16 INK4A overexpression is frequently detected in tumour-free tonsil tissue without association with HPV.

Authors:  Boris Klingenberg; Harriët C Hafkamp; Annick Haesevoets; Johannes J Manni; Pieter J Slootweg; Soenke J Weissenborn; Jens P Klussmann; Ernst-Jan M Speel
Journal:  Histopathology       Date:  2010-06       Impact factor: 5.087

7.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells.

Authors:  S Jeon; B L Allen-Hoffmann; P F Lambert
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors.

Authors:  Liselotte Dahlgren; Hanna Mellin; Danny Wangsa; Kerstin Heselmeyer-Haddad; Linda Björnestål; Johan Lindholm; Eva Munck-Wikland; Gert Auer; Thomas Ried; Tina Dalianis
Journal:  Int J Cancer       Date:  2003-11-01       Impact factor: 7.396

9.  Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.

Authors:  Dohun Pyeon; Michael A Newton; Paul F Lambert; Johan A den Boon; Srikumar Sengupta; Carmen J Marsit; Craig D Woodworth; Joseph P Connor; Thomas H Haugen; Elaine M Smith; Karl T Kelsey; Lubomir P Turek; Paul Ahlquist
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

Review 10.  Human papillomavirus in HNSCC: a European epidemiologic perspective.

Authors:  Lisa Licitra; Giulia Zigon; Gemma Gatta; Maria-José Sánchez; Franco Berrino
Journal:  Hematol Oncol Clin North Am       Date:  2008-12       Impact factor: 3.722

View more
  17 in total

Review 1.  Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.

Authors:  Farhoud Faraji; Munfarid Zaidi; Carole Fakhry; Daria A Gaykalova
Journal:  Microbes Infect       Date:  2017-06-12       Impact factor: 2.700

2.  Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx.

Authors:  Lei Jin; Erich M Sturgis; Xiaolin Cao; Xicheng Song; Taufiq Salahuddin; Qingyi Wei; Guojun Li
Journal:  FASEB J       Date:  2013-02-21       Impact factor: 5.191

Review 3.  Human papillomavirus associated head and neck squamous cell carcinoma: Controversies and new concepts.

Authors:  Nuzhat Husain; Azfar Neyaz
Journal:  J Oral Biol Craniofac Res       Date:  2017-09-01

4.  Characterisation of seven newly established head and neck squamous cell carcinoma cell lines.

Authors:  Tibor Görögh; Elgar Susanne Quabius; Patrick Meyer; Markus Hoffmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-04       Impact factor: 2.503

5.  Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.

Authors:  Daniel L Miller; J Wade Davis; Kristen H Taylor; Jeff Johnson; Zonggao Shi; Russell Williams; Ulus Atasoy; James S Lewis; M Sharon Stack
Journal:  Am J Pathol       Date:  2015-01-05       Impact factor: 4.307

6.  Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status.

Authors:  Stein Lybak; Borghild Ljøkjel; Hilde Haave; Àsa Karlsdottir; Olav K Vintermyr; Hans Jørgen Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-04       Impact factor: 2.503

7.  Integrated, DC voltage-driven nucleic acid diagnostic platform for real sample analysis: Detection of oral cancer.

Authors:  Zdenek Slouka; Satyajyoti Senapati; Sunny Shah; Robin Lawler; Zonggao Shi; M Sharon Stack; Hsueh-Chia Chang
Journal:  Talanta       Date:  2015-05-06       Impact factor: 6.057

8.  Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.

Authors:  Martin Steinau; Mona Saraiya; Marc T Goodman; Edward S Peters; Meg Watson; Jennifer L Cleveland; Charles F Lynch; Edward J Wilkinson; Brenda Y Hernandez; Glen Copeland; Maria S Saber; Claudia Hopenhayn; Youjie Huang; Wendy Cozen; Christopher Lyu; Elizabeth R Unger
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

9.  Rational Design of Peptide Vaccines Against Multiple Types of Human Papillomavirus.

Authors:  Sumanta Dey; Antara De; Ashesh Nandy
Journal:  Cancer Inform       Date:  2016-06-01

Review 10.  Current Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers.

Authors:  Sunny S Shah; Satyajyoti Senapati; Flora Klacsmann; Daniel L Miller; Jeff J Johnson; Hsueh-Chia Chang; M Sharon Stack
Journal:  Cancers (Basel)       Date:  2016-09-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.